| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |